| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.5M | +1310.2% |
| Cost of Revenue | $5.4M | +1208.4% |
| Gross Profit | $1.0M | +2310.2% |
| R&D Expense | $2K | — |
| SG&A Expense | $1.7M | +48.9% |
| Operating Income | -$1.0M | +39.8% |
| Pre-tax Income | -$1.1M | +36.4% |
| Net Income | -$1.1M | +36.6% |
| EPS (Basic) | $0.01 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $265K | +183.1% |
| Accounts Receivable | $66K | +210.0% |
| Current Assets | $821K | +34.8% |
| Total Assets | $4.3M | +9.8% |
| Current Liabilities | $1.4M | +69.7% |
| Total Liabilities | $1.5M | +57.8% |
| Stockholders' Equity | $1.4M | -13.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$468K | +82.2% |
| Investing Cash Flow | -$270K | +74.6% |
| Financing Cash Flow | $909K | -44.5% |
| +150.0% |